The 5' cap structure of RNA polymerase II transcripts and the poly(A) tail found at the 3' end of most mRNAs have been demonstrated to play multiple roles in gene expression and its regulation. In the first part of this review we will concentrate on the role played by the cap in premRNA splicing and how it may contribute to efficient and specific substrate recognition. In the second half, we will discuss the roles that polyadenylation has been demonstated to play in RNA metabolism and will concentrate in particular on an elegant mechanism where regulation of polyadenylation is used to control gene expression.
INTRODUCTION
The 5 ' cap structure of RNA polymerase II (pol II) transcripts, (m7G(5/)ppp(5')N), and the poly(A) tail found at the 3' end of most mRNAs have been shown to play multiple roles in gene expression and its regulation. The cap structure is added cotranscriptionally (Salditt-Georgieff et al., 1980) and is in general not further modified. One of the exceptions to this are the pol II transcribed spliceosomal U snRNAs. After export from the nucleus, the cap o f these RNAs is modified in the cytoplasm from a m7G to a m 2,2'7G cap structure in a reaction which is dependent on an intact Sm binding site, the site through which these RNAs bind to a group of common (Sm) proteins. In the case of the U snRNAs this modification can facilitate nuclear import (reviewed by Izaurralde and Mattaj, 1992a) .
The poly(A) tail found at the 3' end of most mRNAs is, in contrast to the cap, a highly dynamic modification. The length of the poly(A) tail has been shown to vary at different stages during the gene expression pathway. It is thought to play a role in RNA stability (Decker and Parker, 1994) , and also to be important in the developmental regulation of mRNA translation (Wickens, 1990) . Polyadenylation of the 3' end of prokaryotic transcripts has also been shown to play a role in RNA stability (reviewed by Cohen, 1995) indicating perhaps the ancient nature of this mechanism for modulating gene expression.
The remainder of this review is in two sections. In the first part, recent developments in elucidating the role played by the cap in pre-mRNA splicing are discussed. In the second part, the factors involved in 3' end processing and polyadenylation, and how the U1A protein interacts with them to autoregulate expression o f its own mRNA, are reviewed.
THE CAP STRUCTURE
The cap structure, (m7G(5')ppp(5')N), found at the 5' end of all RNA pol II transcripts, has been long known to play multiple roles in the gene expression pathway. Capping of nascent transcripts occurs co-transcriptionally (SaldittGeorgieff et al., 1980) . In nuclear run-on experiments it has been demonstrated, in the case of the Drosophila heat shock genes, that capping takes place during a window when approx imately 20-30 nucleotides of the nascent RNA have been syn thesized (Rasmussen and Lis, 1993) . Thus it is likely that capping is the first postranscriptional RNA modification to take place. Characterisation o f mutants in the RNA guanylyltransferase (capping enzyme) have also demonstrated the impor tance of this modification for viability in both Saccharomyces cerevisiae and Schizosaccharomyces pombe (Shibagaki et al., 1992; Shuman et al., 1994) .
Roles of the cap structure
The ability of the cap to protect mRNA from 5' exoribonucleases was one of its first described functions (Furuichi et al., 1977; Shimotohno et al., 1977) . Other processes where the cap has been shown to be of importance are shown diagramatically in Fig. 1 . The cap has been shown to play a role in pre-mRNA splicing both in vitro (Konarska et al., 1984; Krainer et al., 1984; Edery and Sonnenberg, 1985; Patzelt et al., 1987 and in vivo using microin jected Xenopus oocytes (Inoue et al., 1989) . Nuclear export of mRNAs (Jaramolowski et al., 1994) and especially of U snRNAs has also been shown to be facilitated by the cap in vivo (Hamm and M attaj, 1990, Izaurralde et al., 1992) . Finally, efficient mRNA translation also requires the cap stucture. In translation, the cap is recognised by the cap binding protein eIF-4E which is part of a multi-protein complex (eIF-4F) required for translational initiation (Son nenberg, 1988; Rhoads, 1988) .
The available evidence suggests that the nuclear functions of the cap are mediated through protein factors which recognise this modification specifically. Several such activities have been described in nuclear extracts although most have not Fig. 1 . The cap is involved in multiple aspects o f RNA metabolism. Shortly after the initiation of transcription RNA polymerase II, the RNAs are capped. Splicing of the pre-mRNA, nuclear export and translation all show varying degrees of dependence on the cap structure. This is indicated by an arrow connecting the cap and the process affected.
been fully characterised (e.g. Patzelt et al., 1983; Rozen and Sonnenberg, 1987) . W e have recently described the purification o f a nuclear cap binding com plex (CBC) w hich specifically recognises the m ono-m ethyl guanosine cap structure. CBC has tw o com po nents, C B P80 (O hno et al., 1990; ) and a second sm aller subunit C B P20 . W e dem onstrated that im m uno-depletion o f CBC from nuclear splicing extracts could efficiently inhibit splicing o f an A den ovirus pre-m RN A . A nalysis o f the splicing defect caused by CBC depletion show ed that an early step in spliceosom e assem bly w as inhibited. This inhibition o f splicing could be relieved by adding back CBC purified from H eL a cell extracts.
T he spliceosom e cycle and pre-m R N A splicing
Splicing out o f intronic sequences from pre-m R N A s takes place in a large dedicated ribonucleoprotein com plex called the spliceosom e. W ithin the spliceosom e tw o sequential transesterification reactions take place to produce the m ature m R N A and the intron lariat (Fig. 2) .
M any o f the com ponents o f the spliceosom e have been described, although the functions o f m ost rem ain poorly char acterised. The spliceosom e consists o f the five spliceosom al sm all nuclear RN A s (snRN A s) (U l, U2, U 4/U 6 and U 5) and a large num ber o f associated proteins. T he snR N A s are found as sm all nuclear ribonucleoprotein particles (snRN Ps) com posed o f one RN A (with the exception o f the U 4/U 6 Fig. 2 . Simplified schematic representation of the spliceosome assembly/disassembly cycle. The pre-mRNA branch point is marked by a filled circle. The various stages of spliceosome assembly which can be indentified in vitro, together with their snRNP composition, are labelled. A summary of the assembly steps is given in the text. For reasons of clarity the numerous non-snRNP protein splicing factors, with the exception o f U2AF and CBC, are omitted. The evidence that CBC stays associated with the RNA throughout the cycle is discussed in the text. particle), a set o f Sm core proteins, w hich are com m on to all spliceosom al snR N Ps, and a num ber o f proteins specific for each particle (for exam ple the U l snR N P specific A protein; review ed by L uhrm ann et al., 1990) . In addition to the snR N Ps there are a large num ber o f non-snR N P splicing factors w hose role in splicing is currently under active investigation (review ed by Lam m and Lam ond, 1994) .
T he basic steps o f spliceosom e assem bly w hich can be separated in vitro are show n in Fig. 2 . All the spliceosom al snR N Ps have been show n, but for sim plicity m ost o f the nonsnR N P factors have been om itted. Prior to its sequestration to the splicing pathw ay, the pre-m R N A is com plexed w ith the heterogenous nuclear RN P proteins. This packaging may be im portant fo r the follow ing steps. T he first pre-splicing com plex w hich can be detected is the E (for early) com plex w hich form s on the pre-m R N A in the absence o f A TP (M ichaud and R eed, 1991) . A nalysis o f this com plex has show n that U l snR N P is bound to the 5 ' splice site and the non-snRNP splicing factor U2 auxiliary factor (U2AF) is bound to the poly-pyrimidine tract and may bring the 5' and 3' splice sites into close proximity (Michaud and Reed, 1993) . Additional proteins are also found in E complex although their roles in complex formation are not clear. It has been postulated that formation of E complex is the step which commits the premRNA to the splicing pathway (Michaud and Reed, 1991) although definitive proof is still required. A U1 containing 'commitment com plex' that is the first detectable precursor to the spliceosome has been previously described in yeast (Rosbash and Séraphin, 1991) , and this may be the equivalent to the E complex. In the next step, U2 snRNP associates with the branch point sequence to form the A complex in a process which requires ATP and U2AF (Fig. 2) . The mature spliceo some is then formed when the U4/6.U5 tri-snRNP joins the A complex to form B complex, the mature spliceosome. This undergoes the first step of catalysis (complex C) and the second catalytic step takes place to produce the mature messenger RNA and the intron lariat. The mature mRNA is then released and exported to the cytoplasm while the intron lariat is debranched and degraded. In vivo the spliceosome is then dis assembled and the factors take part in further rounds of splicing. This process of assembly, splicing, disassembly and release of the spliceosome components is referred to as the splicing cycle.
CBC is required for early steps in spliceosome assembly
The complexity of the spliceosome may in part reflect the need to accurately recognise and process pre-mRNAs, and evidence is accumulating that multiple proof-reading events take place during spliceosome assembly to ensure that only bona fide introns are recognised. However, although the role of the snRNAs as determinants of splice site selection and their role in accuracy of cleavage has been extensively characterised (reviewed by Newman, 1994) very little is known about how an intron is recognised by protein factors in the steps preceding spliceosome assembly. Recent evidence from our laboratory suggests that the cap of the pre-mRNA may be involved in this process.
When splicing is inhibited, either in vitro or in vivo by cap analogues, no accumulation of splicing intermediates is observed (Konarska et al., 1984; Krainer et al., 1984; Edery and Sonnenberg, 1985; Patzelt et al., 1987; Inoue et al., 1989; Izaurralde et al., 1994) . Native gel analysis of spliceosome formation in CBC depleted extracts showed that levels of A complex formation were markedly reduced compared to the control extracts . As a consequence, the levels of B and C complex formation were also reduced (see Fig. 2 ). Together, these observations raise the exciting possi bility that CBC may be involved in the steps required to recognise the pre-mRNA. In support of this idea, recent immuno-precipitation experiments have shown that CBC is found to be associated with the pre-mRNA as well as the splicing intermediates and mature message (Joe Lewis, unpub lished observations; also summarised in Fig. 2 ). One attractive model is that CBC bound to the cap defines an RNA as a potential splicing substrate and can directly or indirectly facil itate binding of the U1 snRNP to the 5' splice site of the premRNA. One prediction of this model would be that CBC should be required for E complex formation. In order to test this model, work is underway to determine at exactly which step CBC is required in pre-spliceosome complex formation.
Another related, and by no means mutually exclusive, model is that CBC interacts in concert with members of the SR splicing factor family to promote recognition of the premRNA. These proteins are characterised by the presence of arginine-serine dipeptide repeats and an RNA recognition motif (Zahler et al., 1992; reviewed by Lamm and Lamond, 1994) . Evidence is accumulating that members of this family play a role in early steps of spliceosome assembly (Horowitz and Krainer, 1994) . Perhaps the best example in mammalian systems is the alternative splicing of the bovine growth hormone pre-mRNA. Splicing of intron D is dependent on the presence of an exonic splicing enhancer (ESE) which binds specifically the SR protein SF2/ASF (Sun et al., 1993) . Increas ing the amount of SF2/ASF in extracts stimulates splicing of intron D through the ESE showing that it plays a positive role in intron recognition. Recent evidence has shown that physical depletion of U1 snRNP from, or inactivation of U1 snRNP in, splicing extracts and the consequent inhibition of splicing could be overcome by the addition of a fraction enriched in SR proteins (Crispino et al., 1994; Tarn and Steitz, 1994, respec tively) . However, splicing inhibition caused by inactivation of the U2 snRNP could not be overcome by addition of exogenous SR proteins or the splicing factor SC35 (Tarn and Steitz, 1994) suggesting that they are required only for stages preceeding A complex formation. This is supported by data which show that SR proteins can enhance E complex formation in splicing extracts (Staknis and Reed, 1994) . W hat is clear is that recognition of intron-containing RNAs will involve many different factors which may not be identical between different RNAs, although cap recognition by CBC may be common to all. Nevertheless it is hoped that some general principles regarding pre-mRNA recognition should emerge from contin uing studies in this area of research.
3' END PROCESSING AND POLYADENYLATION
The 3' end of almost all eukaryotic mRNAs comprises a homopolymer of adenosine residues ranging from 20 to 250 nucleotides in length. The poly(A) tail is post-transcriptionally added to pre-mRNA in the nucleus by a two step process called cleavage and polyadenylation (Fig. 3) which is catalyzed by a complex of proteins. The exact location on the pre-mRNA to which the poly(A) tail is added is called the polyadenylation site. Since it was first detected, the polyadenosine, or poly(A), tail has been proposed to function in the regulation of nearly every aspect in the biosynthesis and activity of mRNA. Of these functions, the ones for which experimental evidence exists include: (1) regulation o f translational efficiency of mRNA during oocyte maturation (Wickens, 1990); (2) regula tion of the mRNA degradation pathway (Bernstein and Ross, 1989; Decker and Parker, 1994) ; (3) being required for trans lation of yeast mRNAs (Sachs, 1993; Jackson and Standart, 1990) , which would help to direct ribosomes to translate only intact mRNA; and possibly (4) being required for mRNA export from the nucleus. Besides affecting the biological activity of mRNA, the choice of the polyadenylation site can have dramatic effects on both the spatial and temporal expression of mRNA-encoded genes. The majority of tran reaction. W ithin the nucleus the factors necessary for cleavage are assembled onto the AAUAAA sequence found in the capped premRNA transcript. DSE, downstream sequence element. The abbreviations for the proteins can be found in the text. The scissors indicates that the complex is poised to endonucleolytically cleave the substrate pre-mRNA in two. The downstream half is degraded in the nucleus while the upstream half undergoes polyadenylation. W hen about 250 adenosine (A) residues are added the reaction stops and the processed mRNA is exported to the cytoplasm. scription units have only one polyadenylation site. H ow ever, a num ber o f genes are know n to have alternative polyadenyla tion sites w hich are used to regulate the expression o f their protein products (L eff et al., 1986) .
C leavage and polyadenylation o f pre-m R N A s has been best characterized in vertebrate system s. It is only recently that attention has becom e focused on understanding these reactions in yeast, therefore this review will focus prim arily on w hat has been learned from vertebrates.
RNA sequences
The A A U A A A m otif, w hich is invariably found 10-30 nucleotides upstream o f the polyadenylation site in higher eukaryotes, is the best understood and m ost w ell-conserved d s-ac tin g R N A elem ent that is required for cleavage and polyadenylation to occur. Saturation m utagenesis o f this m otif along w ith analysis of the frequencies o f naturally occuring variants leads to the conclusion that m ore than 98% o f these m otifs are o f the A A U A A A or A U U A A A type (Sheets et al., 1990 ). Because A A U A A A sequences are found at other locations scattered throughout m R N A s it was self-evident that at least one other RN A elem ent m ust be necessary to define the polyadenylation site. O ne such additional elem ent, the DSE, dow nstream sequence elem ent, is required for cleavage and polyadenylation and is found dow nstream o f the cleavage site (review ed by W ahle, 1995). D SEs are found either alone o r in several copies and contain a rather degenerate consensus sequence. They tend to be U-or G U rich, and have accord ingly also been called U or G -U rich elem ents. D SEs are thought to function in selecting w here cleavage and poladenylation will take place (Chou et al., 1994; M acD onald et al., 1994) . In addition to the D SE there are oth er R N A elem ents w hich m odulate the efficiency o f cleavage and polyadenyla tion. These other elem ents are found in close proxim ity, upstream or dow nstream , to the A A U A A A sequence. They have been studied in viruses, w here life-cycle dependent changes in polyadenylation site usage are com m on.
Protein factors and the reaction pathw ay
T he developm ent o f an in vitro cleavage and polyadenylation system about 10 years ago (M oore and Sharp, 1985) has led to the identification, cloning and characterizing o f m ost o f the protein factors involved in cleavage and polyadenylation. In vivo the cleavage and polyadenylation reactions are tightly coupled (the cleavage interm ediate is not detectable) m aking it difficult to study these tw o reactions separately. H ow ever, m ethods were developed that perm itted cleavage and polyadenylation to occur as independent reactions in vitro, enabling each o f the protein factors to be assigned to a p artic ular reaction or to both reactions. T he results o f a large body o f w ork are sum m arized in Fig. 3 w hich gives the current state o f know ledge about the factors that m ediate the cleavage and polyadenylation reaction (for review s see W ahle, 1995; and W ahle and K eller, 1992) . W hile the details o f w hat is show n in Fig. 3 m ay change as w ork progresses it is likely that the basic outline w ill be correct.
C leavage
U pon synthesis o f the pre-m R N A , a com plex o f proteins assem bles at or around the A A U A A A sequence (see Fig. 3 ; G ilm artin and N evins, 1989) . Probably one o f the first factors to bind is called C PSF for cleavage and polyadenylation speci ficity factor (Bienroth et al., 1991; M urthy and M anley, 1992) . H ighly purified C PSF can bind specifically to RN A s contain ing the A A U A A A sequence (K eller et al., 1991) . The CPSF-A A U A A A com plex serves as a nucleation point through w hich the rem aining cleavage factors are recruited. CStF, cleavage and stim ulatory factor, has been cloned and binds to the D SE w hich is found dow nstream o f the cleavage site (Takagaki et al., 1990; G ilm artin and N evins, 1991) . S ubsequent to binding the RN A , C StF stabilizes the C PSF-A A U A A A com plex. C leavage factors (CFs) are also necessary for the cleavage reaction to occur, but they rem ain poorly characterized. The protein factor(s) w hich carries out the endonucleolytic cleavage of the RN A backbone has not been identified b ut it is believed that it w ill be one o f these CFs. T he final factor necessary for efficient cleavage in vitro is, curiously, poly(A ) polym erase (PA P), the enzym e w hich catalyzes the addition o f the poly(A ) tail (Christofori and Keller, 1989) , although this m ay not be the case for all polyadenylation signals (Takagaki et al., 1989) . O nce the com plex is assem bled the phosphodiester backbone o f the RN A is cleaved, resulting in tw o RNA fragm ents. T he upstream RN A fragm ent has a 3'-O H and sub sequently undergoes polyadenylation (see below ) w hereas the dow nstream R N A fragm ent is rapidly degraded in the nucleus. A fter cleavage, C StF and the CFs may exit the cleavage and polyadenylation com plex leaving only C PSF and PA P still bound to the A A U A A A sequence. The evidence for this com es from in vitro experim ents w here it is possible to reconstitute specific polyadenylation (see below ) in the absence o f C StF and the CFs.
P olyadenylation
In the polyadenylation reaction a poly(A ) tail is added to the 3'-O H end o f the upstream RNA fragm ent by PAP. Purified PAP from either H eLa cells or recom binant PA P are capable o f inefficiently polyadenylating any RN A (including tR N A s, rRN A or snR N A s) that has a free 3'-O H Raabe et al., 1991) . Such polyadenylation does not occur in vivo and is therefore called non-specific polyadenylation in order to differentiate it from specific polyadenylation in w hich only RN A s having an A A U A A A sequence are polyadenylated. Specific polyadenylation also requires the presence o f CPSF. Thus, in vitro, these two factors are sufficient to reconstitute A A U A A A -dependent polyadenylation. Reconstituted polyadenylation occurs in 3 distinct phases (Sheets and W ickens, 1989) . In the first phase poly(A ) addition is slow and distributive and depends on the A A U A A A sequence and CPSF. In the second phase, w hen the grow ing poly(A ) tail reaches a length o f 10 residues, poly(A ) addition becom es rapid and processive and depends on the poly(A ) tail and a third factor w hich enters the reaction called PABII, poly(A ) binding protein II (W ahle, 1991) . In the third phase, after the addition o f about 200 adenosine residues, the rate o f polyadenylation slows considerably, eventually stopping at around 250 adenosine residues, w hich is the length o f poly(A ) tails added to m R N A s in the nucleus in vivo. PABII also functions in controlling the final length o f the poly (A) tail.
U1A protein auto regu latio n by inhibition of p o lyadenylation
T he U1 snR N P particle is involved in splicing o f pre-m R N A by binding to the 5 ' splice site o f introns (see first part o f review ). T he U1 snR N P particle com prises U1 snR N A com plexed w ith the Sm core proteins and three U1 specific proteins. O ne o f these is the U 1A protein w hich binds with high affinity to the second stem loop o f U 1 snRNA (Scherly et al., 1989) . W ithin the loop part o f this hairpin is the sequence A U U G C A C that has been show n to be required for specific binding o f U 1A protein. M ore recently it was discovered that the U 1A protein also specifically binds to a RN A sequence found adjacent to the polyadenylation signal o f the U1A prem R N A (B oelens et al., 1993) . A s show n in Fig. 4 this RN A sequence contains 2 short m otifs w hich closely or perfectly m atch the U 1A binding site in stem -loop 2 o f U 1 snRNA. A lso show n is the secondary structure for this RN A sequence, w hich w as determ ined by a com bination o f com puter prediction, phy logenetic analysis, enzym atic and chem ical structure probing, and m utagenesis (van G elder et al., 1993) . N ote that the 2 sequences (A U U G C /U A C ) w ithin this structure are in single stranded loops (as they are found in stem -loop 2 o f U1 snR N A ) Fig. 4 . Mechanism for how U1A protein autoregulates its own production by inhibition of polyadenylation. Vertebrate CPSF and PAP, the factors needed for the polyadenylation step of the cleavage and polyadenylation reaction, are shown bound to the U1A premRNA. The cleavage reaction has already occurred. The shaded circle is U1A protein which, when in excess, binds as two molecules to the U1A pre-mRNA, shown in its characteristic secondary structure. Once bound the U lA -pre-m R N A complex bypasses RNAbound CPSF and specifically interacts with and inhibits the activity o f vertebrate PAP. The shaded area in the PAP oval represents a domain necessary for PAP to bind to and be inhibited by RNAbound U1A protein. Likewise, the stippled area within the U1A shaded circle represent a small domain which is needed to interact with and inhibit PAP. and that one m olecule o f U 1A protein binds each sequence. W hen both sites are occupied by U 1A protein, polyadenylation o f the U1A pre-m R N A is inhibited both in vitro and in vivo . M utagenesis studies dem onstrated that one m olecule o f RN A -bound U1A protein is not sufficient to efficiently inhibit polyadenylation (van G elder et al., 1993) . U1A protein inhibition o f its own polyadenylation results in a dow n-regulation o f the U 1A m R N A levels in vivo. Fig. 4 show s how U1A autoregulation is thought to work. W hen there is excess U1A protein in the cell, it binds its ow n pre-m RN A , inhibiting the cleavage and polyadenylation reaction. U npolyadenylated U1A pre-m R N A is thought to rem ain in the nucleus (where it is probably rapidly degraded). This reduces the effective concentration o f U 1A m R N A resulting in a reduction o f U 1A protein synthesis.
In vitro studies have elucidated the m echanism o f U 1A protein inhibition o f polyadenylation (G underson et al., 1994) . Surprisingly, U 1A protein com plexed w ith U 1A pre-m R N A has no detectable effect on the efficiency o f cleavage. It is, instead, the polyadenylation rection w hich is inhibited. This m ay result in a m ore effective form o f regulation because any cryptic dow nstream polyadenylation sites w hich could be potentially used w ill be rem oved from the RNA.
Since specific polyadenylation requires only C PSF and PAP, U 1A protein m ust be blocking one or both o f these factors. It w as show n that R N A -bound U 1A protein had no effect on C P SF binding to the A A U A A A recognition sequence, however, it efficiently blocks the non-specific polyadenylation activity of mammalian PAP (Gunderson et al., 1994) . This reg ulatory mechanism can be reconstituted in vitro using only recombinant PAP, U1A protein and substrate RNA. More unexpectedly, the RNA-bound U1A protein does not inhibit the polyadenylation activity of yeast PAP indicating that RNAbound U1A protein is not sterically blocking access of PAP to the 3'-OH of the substrate RNA. In fact, RNA bound U1A protein specifically interacts directly with mammalian, but not yeast, PAP. More recently it has been shown that small domains in both U1A and PAP are needed for this interaction (S. I. Gunderson, unpublished observations).
The U1A autoregulatory circuit is the best understood example at the molecular level of regulation of RNA process ing, and is notable because U1A protein and PAP are involved in distinct separable steps (splicing versus cleavage and polyadenylation) in the pre-mRNA processing pathway. Recent reports have blurred the lines separating these two steps. For example it has now been shown in vivo that splicing of the final intron is coupled to the cleavage and polyadenylation reaction (Niwa and Berget, 1991) . In support of this, anti-Ul snRNP antibodies, and not other anti-RNP antibodies, specifically block cleavage and polyadenylation in HeLa nuclear extracts (Moore and Sharp, 1985; Hashimoto and Steitz, 1986) . There are also a number of reports which have shown that the U1 snRNP particle is in some way associated with PAP (Raju and Jacob, 1988; Wassarmann and Steitz, 1993) . Perhaps the U1A protein within the particle is contributing to this interaction with PAP. W hat the biological function of this interaction is remains an open question, however, integration of the multiple process ing events that must occur to any pre-mRNA is clearly a desirable goal. Additionally, the expression of a growing number of genes seems to be controlled by a competition between utilization of adjacent splicing and cleavage/ polyadenylation signals. All of these examples point towards the idea that these two processing reactions are intimately connected in vivo. Thus, we can expect in the near future to learn more about how and why the splicing and polyadenyla tion machineries communicate with each other.
